GROGAN DONNA ROY
SEC insider (Form 3/4/5 filer). CIK 0001788455. Director at C4 Therapeutics, Inc. (CCCC). 11 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WATERTOWN, MA.
Companies GROGAN DONNA ROY has filed insider reports for
- C4 Therapeutics, Inc. (CCCC): Director
GROGAN DONNA ROY
CIK: 0001788455
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
C4 Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Oct 1, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect4.6K shares at avg. $3.14$15K - Jul 1, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect3.3K shares at avg. $4.34$14K - Jun 24, 2026CCCC
C4 Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
62K shares- - Apr 1, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect5.4K shares at avg. $2.70$14K - Jan 2, 2026CCCC
C4 Therapeutics, Inc.
AwardDirect7.5K shares at avg. $1.93$15K - Oct 1, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect6.7K shares at avg. $2.15$14K - Jul 1, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect9.6K shares at avg. $1.51$15K - Jun 18, 2025CCCC
C4 Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
35.5K shares- - Apr 1, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect9.6K shares at avg. $1.44$14K - Jan 2, 2025CCCC
C4 Therapeutics, Inc.
AwardDirect3.8K shares at avg. $3.66$14K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | CCCC C4 Therapeutics, Inc. | Award | 4,618 | $3.14 | $14,501 | Direct |
| Jul 1, 2026 | CCCC C4 Therapeutics, Inc. | Award | 3,341 | $4.34 | $14,500 | Direct |
| Jun 24, 2026 | CCCC C4 Therapeutics, Inc. | Award Stock Option (Right to Buy) | 62,000 | - | - | Direct |
| Apr 1, 2026 | CCCC C4 Therapeutics, Inc. | Award | 5,370 | $2.70 | $14,499 | Direct |
| Jan 2, 2026 | CCCC C4 Therapeutics, Inc. | Award | 7,513 | $1.93 | $14,500 | Direct |
| Oct 1, 2025 | CCCC C4 Therapeutics, Inc. | Award | 6,740 | $2.15 | $14,491 | Direct |
| Jul 1, 2025 | CCCC C4 Therapeutics, Inc. | Award | 9,609 | $1.51 | $14,510 | Direct |
| Jun 18, 2025 | CCCC C4 Therapeutics, Inc. | Award Stock Option (Right to Buy) | 35,500 | - | - | Direct |
| Apr 1, 2025 | CCCC C4 Therapeutics, Inc. | Award | 9,581 | $1.44 | $13,749 | Direct |
| Jan 2, 2025 | CCCC C4 Therapeutics, Inc. | Award | 3,757 | $3.66 | $13,751 | Direct |
1-10 of 11 transactions